All Officials
Select methods...
Lobbying Records (Page 1 of 10)
2025-09-19
Politician(s) lobbied: Peter Burke (Minister), Department of Enterprise, Trade and Employment; Brian Keegan (Special Advisor), Department of Enterprise, Trade and Employment
Intent: Reform of R&D tax credit to ensure that Ireland remains competitive in attracting pharmaceutical investment and to support industry innovation.
Methods: Meeting
Details & Methods:
| Method | Description |
|---|---|
| — | Reform of R&D tax credit |
2025-09-19
Politician(s) lobbied: Simon Harris (An Taoiseach), Department of the Taoiseach; Micheál Martin (Tánaiste and Minister), Department of Foreign Affairs; Jennifer Carroll MacNeill (Minister), Department of Health; Pádraig O'Sullivan (TD), Dáil Éireann, the Oireachtas; Colm Burke (TD), Dáil Éireann, the Oireachtas; Shane Moynihan (TD), Dáil Éireann, the Oireachtas; Pádraig Rice (TD), Dáil Éireann, the Oireachtas; Marie Sherlock (TD), Dáil Éireann, the Oireachtas; Emer Currie (TD), Dáil Éireann, the Oireachtas
Intent: To highlight the importance of reform of the reimbursement system so that patients can access new medicines as soon as possible::That the state will speed up access to medicines and increase investment in innovative medicines in the context of the IPHA framework agreement re-negotiations
Methods: Email, Letter, Meeting
Details & Methods:
| Method | Description |
|---|---|
| — | Ireland's medicine reimbursement system and funding for access to new medicines and vaccines |
2025-09-19
Politician(s) lobbied: Micheál Martin (An Taoiseach), Department of the Taoiseach; Joanne Lonergan (Programme Manager - Tánaiste), Department of the Taoiseach; Deirdre Gillane (Chief of Staff), Department of the Taoiseach; Simon Harris (Tánaiste and Minister), Department of Defence; Peter Burke (Minister), Department of Enterprise, Trade and Employment; Geraldine Byrne Nason (Ambassador), Department of Foreign Affairs; Conor Glynn (Special Advisor to the Tanaiste), Department of the Taoiseach; Shane Moynihan (TD), Dáil Éireann, the Oireachtas; Colm Burke (TD), Dáil Éireann, the Oireachtas; Clare Mungovan (Special Adviser), Department of the Taoiseach; Seamus McGrath (TD), Dáil Éireann, the Oireachtas
Intent: To highlight our concerns about the inclusion of pharmaceuticals in tariffs, the timing for entry into force, and the need for a zero-tariff pathway that includes innovative medicines. ::To highlight the potential impact of Most Favoured Nation pricing for pharmaceuticals in the US and the need for further investment in innovative medicines in Europe that recognises the value of biopharmaceutical innovation
Methods: Email, Phone call, Meeting
Details & Methods:
| Method | Description |
|---|---|
| — | Raise concern about the impact of potential tariffs and related geo-political issues related to the pharmaceutical industry and pricing of medicines globally |
2025-09-19
Politician(s) lobbied: Jennifer Carroll MacNeill (Minister), Department of Health; Kieran O'Donnell (Minister of State), Department of Housing, Local Government and Heritage; Jennifer Murnane O'Connor (TD), Dáil Éireann, the Oireachtas; Professor Mary Horgan (Chief Medical Officer), Department of Health; Shane Moynihan (TD), Dáil Éireann, the Oireachtas; Colm Burke (TD), Dáil Éireann, the Oireachtas; Pádraig O'Sullivan (TD), Dáil Éireann, the Oireachtas; Martin Daly (TD), Dáil Éireann, the Oireachtas; Jerry Buttimer (Minister of State), Department of Rural and Community Development
Intent: Highlight the importance of the roll-out of an RSV National Immunisation Programme for those over 65 years old to reduce the burden of RSV disease which continues to cause illness and hospitalisation among infants and older adults. The spread of RSV is of particular concern in nursing homes and residential healthcare settings and can lead to further respiratory complications for older people. ::Expansion of the infant programme to include a maternal vaccine so that parents have the opportunity to choose between a mother receiving a vaccine during pregnancy or the newborn baby receiving a monoclonal antibody
Methods: Letter, Email, Meeting
Details & Methods:
| Method | Description |
|---|---|
| — | Expansion of the National Immunisation Programme to include RSV protection for infants and older adults |
2025-05-21
Politician(s) lobbied: Pádraig O'Sullivan (TD), Dáil Éireann, the Oireachtas
Intent: To highlight the importance of timely access to genetic testing for those with ATTR-CM in Ireland
Methods: Email
Details & Methods:
| Method | Description |
|---|---|
| — | Treatment of Amyloidosis and ATTR-CM M |
2025-05-21
Politician(s) lobbied: Peter Burke (Minister), Department of Enterprise, Trade and Employment; Micheál Martin (Taoiseach), Dáil Éireann, the Oireachtas; Simon Harris (Tánaiste and Minister), Department of Foreign Affairs; Jennifer Carroll MacNeill (Minister), Department of Health; Laura Mannion (Special Adviser), Department of Enterprise, Trade and Employment; Deirdre Gillane (Chief of Staff), Department of the Taoiseach; Billy Kelleher (MEP), European Parliament
Intent: Highlight negative impact of changes to the EU Pharmaceutical legislation on the Irish economy and EU competitiveness
Methods: Meeting, Email, Letter
Details & Methods:
| Method | Description |
|---|---|
| — | EU Pharmaceutical Legislation proposals |
2025-05-21
Politician(s) lobbied: Simon Harris (An Taoiseach), Department of the Taoiseach; Micheál Martin (Tánaiste and Minister), Department of Foreign Affairs; David Cullinane (TD), Dáil Éireann, the Oireachtas; Jennifer Carroll MacNeill (Minister), Department of Health; Laura Mannion (Special Adviser), Department of Enterprise, Trade and Employment; Peter Burke (Minister), Department of Enterprise, Trade and Employment; Pádraig O'Sullivan (TD), Dáil Éireann, the Oireachtas
Intent: To implement the Mazar's reimbursement review recommendations and publish the working group report ::Faster access to new medicines for patients
Methods: Email, Letter, Meeting
Details & Methods:
| Method | Description |
|---|---|
| — | Ireland's medicine reimbursement system and funding for access to new medicines and vaccines |
2025-05-21
Politician(s) lobbied: Micheál Martin (An Taoiseach), Department of the Taoiseach; Simon Harris (Tánaiste and Minister), Department of Foreign Affairs; Jennifer Carroll MacNeill (Minister), Department of Health; Peter Burke (Minister), Department of Enterprise, Trade and Employment; Laura Mannion (Special Advisor), Department of Enterprise, Trade and Employment; David Cullinane (TD), Dáil Éireann, the Oireachtas
Intent: Highlight the importance of the roll-out of an RSV National Immunisation Programme for those over 65 years old to reduce the burden of RSV disease which continues to cause illness and hospitalisation among infants and older adults. The spread of RSV is of particular concern in nursing homes and residential healthcare settings and can lead to further respiratory complications for older people. ::Expansion of the infant programme to include a maternal vaccine so that parents have the opportunity to choose between a mother receiving a vaccine during pregnancy or the newborn baby receiving a monoclonal antibody
Methods: Letter, Email
Details & Methods:
| Method | Description |
|---|---|
| — | Expansion of the National Immunisation Programme to include RSV protection for infants and older adults |
2025-05-21
Politician(s) lobbied: Micheál Martin (An Taoiseach), Department of the Taoiseach; Joanne Lonergan (Programme Manager - Tánaiste), Department of the Taoiseach; Pauric McPhillips (Special Advisor to the Tanaiste), Department of the Taoiseach; Deirdre Gillane (Chief of Staff), Department of the Taoiseach; Diarmuid Lynch (Special Adviser), Department of the Taoiseach; Paschal Donohoe (Minister), Department of Public Expenditure, NDP Delivery and Reform; Simon Harris (Tánaiste and Minister), Department of Defence; Peter Burke (Minister), Department of Enterprise, Trade and Employment; Laura Mannion (Special Advisor), Department of Enterprise, Trade and Employment; Billy Kelleher (MEP), European Parliament; Geraldine Byrne Nason (Ambassador), Department of Foreign Affairs
Intent: To highlight that tariffs on medicines and their inputs would increase healthcare costs for patients and increase the cost of producing medicines, reducing the competitiveness of pharmaceutical manufacturers that drive innovation. Globally integrated supply chains for medicines means that the impact of tariffs cannot be limited to one country. ::Ensuring pharmaceuticals are exempt from any potential retaliatory tariffs because suchmeasures have a cumulative negative impact, increasing the cost of production andreducing patient access.
Methods: Email, Phone call, Meeting
Details & Methods:
| Method | Description |
|---|---|
| — | Raise concern about the impact of potential tariffs on pharmaceutical manufacturing and supply of medicines to patients globally |
2025-01-21
Politician(s) lobbied: Seán Kelly (MEP), European Parliament
Intent: Raise awareness of the importance of a fact based assessment of the impact of banning PFAS for pharmaceutical manufacturing
Methods: Meeting
Details & Methods:
| Method | Description |
|---|---|
| — | PFAS restrictions |
…
